Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer

1. Levy, B.P.
2. Giaccone, G.
3. Besse, B.
4. Felip, E.
5. Garassino, M.C.
6. Domine Gomez, M.
7. Garrido, P.
8. Piperdi, B.
9. Ponce-Aix, S.
10. Menezes, D.
11. MacBeth, K.J.
12. Risueño, A.
13. Slepetis, R.
14. Wu, X.
15. Fandi, A.
16. Paz-Ares, L.